Chemoembolization as a minimally invasive treatment of primary malignant liver cancer
Background: Hepatocellular carcinoma (HCC) is the most common type of liver cancer and one of the most malignant neoplasms with high incidence and mortality in humans worldwide. The complex nature of the disease and its high resistance to systemic therapies result in poor prognosis for patients wit...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kazimierz Wielki University
2022-10-01
|
| Series: | Journal of Education, Health and Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/JEHS/article/view/39857 |
| _version_ | 1798045255886438400 |
|---|---|
| author | Katarzyna Szklener Weronika Kuryło Anna Rodzajewska Łukasz Światłowski Tomasz Jargiełło Sławomir Mańdziuk |
| author_facet | Katarzyna Szklener Weronika Kuryło Anna Rodzajewska Łukasz Światłowski Tomasz Jargiełło Sławomir Mańdziuk |
| author_sort | Katarzyna Szklener |
| collection | DOAJ |
| description |
Background: Hepatocellular carcinoma (HCC) is the most common type of liver cancer and one of the most malignant neoplasms with high incidence and mortality in humans worldwide. The complex nature of the disease and its high resistance to systemic therapies result in poor prognosis for patients with advanced HCC.
Case Report: In March 2017, the patient was admitted to the Department of Oncological Surgery, where a non-anatomical tumor resection was performed. Three years later, the patient developed a single change in segment 8 of the liver that was a relapse of the neoplastic process. Based on the Bracelon Criteria, the patient was qualified for the 1st stage of chemoembolization using the Seldinger method. In the presented patient as a result of the applied treatment, the neoplastic process was stabilized.
Conclusion: The chemoembolization treatment that was applied to the presented patient turned out to be the correct treatment option. After only the first stage of chemoembolization, the patient regressed the neoplastic lesion.
|
| first_indexed | 2024-04-11T23:17:50Z |
| format | Article |
| id | doaj.art-bcca1f2e5c454ecdb6fc7c060b1e0ef6 |
| institution | Directory Open Access Journal |
| issn | 2391-8306 |
| language | English |
| last_indexed | 2024-04-11T23:17:50Z |
| publishDate | 2022-10-01 |
| publisher | Kazimierz Wielki University |
| record_format | Article |
| series | Journal of Education, Health and Sport |
| spelling | doaj.art-bcca1f2e5c454ecdb6fc7c060b1e0ef62022-12-22T03:57:33ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062022-10-01121010.12775/JEHS.2022.12.10.038Chemoembolization as a minimally invasive treatment of primary malignant liver cancerKatarzyna Szklener0Weronika Kuryło1Anna Rodzajewska2Łukasz Światłowski3Tomasz Jargiełło4Sławomir Mańdziuk5Department of Clinical Oncology and Chemotherapy, Medical University of LublinStudent Research Group at the Department of Clinical Oncology and Chemotherapy, Medical University of Lublin Student Research Group at the Department of Clinical Oncology and Chemotherapy, Medical University of LublinDepartment of Interventional Radiology and Neuroradiology, Medical University of Lublin Department of Interventional Radiology and Neuroradiology, Medical University of Lublin Department of Clinical Oncology and Chemotherapy, Medical University of Lublin Background: Hepatocellular carcinoma (HCC) is the most common type of liver cancer and one of the most malignant neoplasms with high incidence and mortality in humans worldwide. The complex nature of the disease and its high resistance to systemic therapies result in poor prognosis for patients with advanced HCC. Case Report: In March 2017, the patient was admitted to the Department of Oncological Surgery, where a non-anatomical tumor resection was performed. Three years later, the patient developed a single change in segment 8 of the liver that was a relapse of the neoplastic process. Based on the Bracelon Criteria, the patient was qualified for the 1st stage of chemoembolization using the Seldinger method. In the presented patient as a result of the applied treatment, the neoplastic process was stabilized. Conclusion: The chemoembolization treatment that was applied to the presented patient turned out to be the correct treatment option. After only the first stage of chemoembolization, the patient regressed the neoplastic lesion. https://apcz.umk.pl/JEHS/article/view/39857hepatocellular carcinomacomplete responsechemoembolisationoutcome |
| spellingShingle | Katarzyna Szklener Weronika Kuryło Anna Rodzajewska Łukasz Światłowski Tomasz Jargiełło Sławomir Mańdziuk Chemoembolization as a minimally invasive treatment of primary malignant liver cancer Journal of Education, Health and Sport hepatocellular carcinoma complete response chemoembolisation outcome |
| title | Chemoembolization as a minimally invasive treatment of primary malignant liver cancer |
| title_full | Chemoembolization as a minimally invasive treatment of primary malignant liver cancer |
| title_fullStr | Chemoembolization as a minimally invasive treatment of primary malignant liver cancer |
| title_full_unstemmed | Chemoembolization as a minimally invasive treatment of primary malignant liver cancer |
| title_short | Chemoembolization as a minimally invasive treatment of primary malignant liver cancer |
| title_sort | chemoembolization as a minimally invasive treatment of primary malignant liver cancer |
| topic | hepatocellular carcinoma complete response chemoembolisation outcome |
| url | https://apcz.umk.pl/JEHS/article/view/39857 |
| work_keys_str_mv | AT katarzynaszklener chemoembolizationasaminimallyinvasivetreatmentofprimarymalignantlivercancer AT weronikakuryło chemoembolizationasaminimallyinvasivetreatmentofprimarymalignantlivercancer AT annarodzajewska chemoembolizationasaminimallyinvasivetreatmentofprimarymalignantlivercancer AT łukaszswiatłowski chemoembolizationasaminimallyinvasivetreatmentofprimarymalignantlivercancer AT tomaszjargiełło chemoembolizationasaminimallyinvasivetreatmentofprimarymalignantlivercancer AT sławomirmandziuk chemoembolizationasaminimallyinvasivetreatmentofprimarymalignantlivercancer |